ENZC (Enzolytics) Total Operating Expense: $1.92 Mil (TTM As of Jun. 2011)


What is Enzolytics Total Operating Expense?

Enzolytics ENZC -10.00% Total Operating Expense is $1.92 Mil as of Jun. 2011.

Enzolytics's Total Operating Expense for the three months ended in Jun. 2011 was $0.23 Mil. Enzolytics's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2011 was $1.92 Mil.

Enzolytics Total Operating Expense Related Terms

Enzolytics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Enzolytics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Total Operating Expense Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Total Operating Expense
0.04 0.06 0.95 2.91

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.63 0.81 0.25 0.23

Enzolytics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.92 Mil mean?
Enzolytics (ENZC) has a Total Operating Expense of $1.92 Mil as of Jun. 2011. Total operating expense is the primary recurring expense associated with central operations. View historical data on Enzolytics and its competitors.
Is Enzolytics' Total Operating Expense too high?
Enzolytics' current Total Operating Expense is $1.92 Mil.
How does Enzolytics' Total Operating Expense compare to competitors?
Enzolytics' Total Operating Expense of $1.92 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Enzolytics and its competitors. Enzolytics's current Total Operating Expense is $1.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Total Operating Expense of $1.92 Mil. The current Total Operating Expense is $1.92 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Enzolytics (ENZC), the current Total Operating Expense is $1.92 Mil as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.